FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

IntegraDose Compounding Services Vasopressin 2 Units/2 mL in 0 Recall

Vasopressin 2 Units/2 mL in 0

IntegraDose Compounding Services LLC · Shoreview, MN

Risk level
Class II
Reported by FDA
Jun 24, 2026
Recall ID
D-0593-2026
Check your lot numberHow we source this data

Summary

IntegraDose Compounding Services recalled Vasopressin 2 Units/2 mL in 0 starting May 18, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0593-2026 on Jun 24, 2026. Reason: Subpotent Drug. Status: Ongoing.

Why it was recalled

Subpotent Drug

Product description

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.

Lot numbers, UPCs & expiration codes

Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026.

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0593-2026
Classification
Class II
Status
Ongoing
Recall initiated
May 18, 2026
FDA report date
Jun 24, 2026
Quantity
287 units
Recall type
Voluntary: Firm initiated
Recalling firm
IntegraDose Compounding Services LLC

Original FDA data

Every field from FDA enforcement report D-0593-2026, exactly as published.

Show all FDA fields
City
Shoreview
State
MN
Status
Ongoing
Country
United States
Event ID
99014
Address
3650 Victoria St N Ste 900
Code information
Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026.
Postal code
55126-2906
Report date
Jun 24, 2026
Product type
Drugs
Recall number
D-0593-2026
Classification
Class II
Recalling firm
IntegraDose Compounding Services LLC
Product quantity
287 units
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Distribution pattern
U.S.A. Nationwide
Recall initiation date
May 18, 2026
Initial firm notification
Letter
Center classification date
Jun 12, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0593-2026, published Jun 24, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls